Literature DB >> 28732801

Bicarbonate in cystic fibrosis.

Karl Kunzelmann1, Rainer Schreiber2, Hans Beat Hadorn3.   

Abstract

BACKGROUND: Cystic fibrosis (CF, mucoviscidosis) is caused by mutations in the gene encoding CF transmembrane conductance regulator (CFTR), which is a chloride and bicarbonate channel necessary for fluid secretion and extracellular alkalization. For a long time, research concentrated on abnormal Cl- and Na+ transport, but neglected bicarbonate as a crucial factor in CF.
METHODS: The present short review reports early findings as well as recent insights into the role of CFTR for bicarbonate transport and its defects in CF.
RESULTS: The available data indicate impaired bicarbonate transport not only in pancreas, intestine, airways, and reproductive organs, but also in salivary glands, sweat duct and renal tubular epithelial cells. Defective bicarbonate transport is closely related to the impaired mucus properties and mucus blocking in secretory organs of CF patients, causing the life threatening lung disease.
CONCLUSIONS: Apart from the devastating lung disease, abrogated bicarbonate transport also leads to many other organ dysfunctions, which are outlined in the present review.
Copyright © 2017 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bicarbonate; CFTR; Cystic fibrosis; Cystic fibrosis transmembrane conductance regulator; Mucoviscidosis; Mucus

Mesh:

Substances:

Year:  2017        PMID: 28732801     DOI: 10.1016/j.jcf.2017.06.005

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  20 in total

1.  Viral Vectors, Animal Models, and Cellular Targets for Gene Therapy of Cystic Fibrosis Lung Disease.

Authors:  Yinghua Tang; Ziying Yan; John F Engelhardt
Journal:  Hum Gene Ther       Date:  2020-04-15       Impact factor: 5.695

2.  Neuropeptide regulation of secretion and inflammation in human airway gland serous cells.

Authors:  Derek B McMahon; Ryan M Carey; Michael A Kohanski; Charles C L Tong; Peter Papagiannopoulos; Nithin D Adappa; James N Palmer; Robert J Lee
Journal:  Eur Respir J       Date:  2020-04-16       Impact factor: 16.671

3.  Therapeutic attenuation of the epithelial sodium channel with a SPLUNC1-derived peptide in airway diseases.

Authors:  James F Collawn; Rafal Bartoszewski; Ahmad Lazrak; Sadis Matalon
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-01-04       Impact factor: 5.464

4.  Safety, Tolerability, and Effects of Sodium Bicarbonate Inhalation in Cystic Fibrosis.

Authors:  Carla Cristina Souza Gomez; Paloma Lopes Francisco Parazzi; Karl Jan Clinckspoor; Renan Marrichi Mauch; Francisco Benedito Teixeira Pessine; Carlos Emilio Levy; Andressa Oliveira Peixoto; Maria Ângela Gonçalves Oliveira Ribeiro; Antônio Fernando Ribeiro; Douglas Conrad; Paul Marquis Quinton; Fernando Augusto Lima Marson; José Dirceu Ribeiro
Journal:  Clin Drug Investig       Date:  2020-02       Impact factor: 2.859

5.  Niclosamide repurposed for the treatment of inflammatory airway disease.

Authors:  Inês Cabrita; Roberta Benedetto; Rainer Schreiber; Karl Kunzelmann
Journal:  JCI Insight       Date:  2019-08-08

Review 6.  Luminal Gastrointestinal Manifestations of Cystic Fibrosis.

Authors:  Samuel J Burton; Christine Hachem; James M Abraham
Journal:  Curr Gastroenterol Rep       Date:  2021-03-23

7.  Citizen-science based study of the oral microbiome in Cystic fibrosis and matched controls reveals major differences in diversity and abundance of bacterial and fungal species.

Authors:  Jesse R Willis; Ester Saus; Susana Iraola-Guzmán; Elena Cabello-Yeves; Ewa Ksiezopolska; Luca Cozzuto; Luis A Bejarano; Nuria Andreu-Somavilla; Miriam Alloza-Trabado; Andrea Blanco; Anna Puig-Sola; Elisabetta Broglio; Carlo Carolis; Julia Ponomarenko; Jochen Hecht; Toni Gabaldón
Journal:  J Oral Microbiol       Date:  2021-05-17       Impact factor: 5.474

Review 8.  Choline in cystic fibrosis: relations to pancreas insufficiency, enterohepatic cycle, PEMT and intestinal microbiota.

Authors:  Wolfgang Bernhard
Journal:  Eur J Nutr       Date:  2020-08-14       Impact factor: 5.614

Review 9.  CFTR Modulators: Does One Dose Fit All?

Authors:  Renske van der Meer; Erik B Wilms; Harry G M Heijerman
Journal:  J Pers Med       Date:  2021-05-24

10.  The Effect of Sodium Bicarbonate, a Beneficial Adjuvant Molecule in Cystic Fibrosis, on Bronchial Epithelial Cells Expressing a Wild-Type or Mutant CFTR Channel.

Authors:  Ilona Gróf; Alexandra Bocsik; András Harazin; Ana Raquel Santa-Maria; Gaszton Vizsnyiczai; Lilla Barna; Lóránd Kiss; Gabriella Fűr; Zoltán Rakonczay; Rita Ambrus; Piroska Szabó-Révész; Fabien Gosselet; Pongsiri Jaikumpun; Hajnalka Szabó; Ákos Zsembery; Mária A Deli
Journal:  Int J Mol Sci       Date:  2020-06-04       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.